/People

Ian Tomlinson

Investor

Investor at Start Codon

Cambridge, England, United Kingdom

Find your path to Ian

Sign up to see every warm intro you have to Ian

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Ian. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

A pharma R&D leader, biotech entrepreneur and antibody engineer. He co-founded and was CSO of Domantis (sold to GSK in 2007 for $454m), later served as SVP and Head of Worldwide Business Development at GSK, and chaired Stevenage Bioscience Catalyst and Apollo Therapeutics.

Colleagues at Start Codon

Frequently asked questions

Who is Ian Tomlinson?
A pharma R&D leader, biotech entrepreneur and antibody engineer. He co-founded and was CSO of Domantis (sold to GSK in 2007 for $454m), later served as SVP and Head of Worldwide Business Development at GSK, and chaired Stevenage Bioscience Catalyst and Apollo Therapeutics.
Where does Ian Tomlinson work?
Ian Tomlinson is at Start Codon.

Founder mafias

Maxion Therapeutics mafia2

Also came through, then founded or led a company.

About this profile. Compiled from public sources — Start Codon's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights